Not Yet RecruitingNot Applicable

Efficacy of LN18178 in Improving Muscle Strength, Aerobic Capacity and Body Composition in Healthy Young Males

120 participantsStarted 2025-08-04

Plain-language summary

The Purpose of the study is to evaluate the efficacy of LN18178 in improving muscle strength, aerobic capacity and body composition in healthy young males.

Who can participate

Age range36 Years – 50 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Untrained healthy male subjects aged between 36 and 50 years with a Body Mass Index (BMI) between 22 and 27 kg/m2.
✓. Willingness to do exercise training program during the course of the study.
✓. Subject considered generally healthy as per health history and routine clinical investigations.
✓. Ability to understand the risks and benefits of the protocol.
✓. Subject should provide written informed consent and agree to be available for regular follow up throughout the study duration.
✓. Subjects who are sexually active must agree to use adequate non-hormonal contraception during the study
✓. Subjects agree to maintain current diet and activity level.
✓. Subject agrees not to start any new therapies for energy boosting supplements or protein supplements or health drinks during the course of the study.

Exclusion criteria

✕. Subjects who are resistance trained or undergoing resistance training.
✕. Subjects with blood pressure more than or equal to 140/90 mmHg, fasting plasma glucose more than 125 mg/dL and abnormal ECG.
✕. Subjects underwent treatment for COVID-19 within last 3 months or tested positive during the study will be excluded.
✕. Evidence or history of musculoskeletal, respiratory, haematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurologic diseases, malignancies.
✕. Subjects diagnosed with sleep apnea or related disorders.
✕. Subjects consuming medications that can interfere with muscle mass such as corticosteroids, testosterone replacement or anabolic drugs.
✕. History of psychiatric disorder that may impair the ability of subjects to provide written informed consent.
✕. Subjects consuming alcohol (more than 3 standard drinks per week) or smokers ( more than 3 cigarettes per day).

What they're measuring

Change in Muscle strength (1-RM leg press)

Timeframe: Week 0, Week 2, Week 4, Week 8 and Week 12

Trial details

NCT IDNCT07092722

SponsorGENCOR Lifestage Solutions

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-15

Contact for this trial

Mr Machiraju Garga

+91 8331015019 machiraju.gls@gmail.com

View on ClinicalTrials.gov More Muscle Strength Recovery trials